These assays measure how a candidate limits viral replication or how antibodies neutralize a virus. They rely on plaque and microneutralization assays, virological methods and lung organoids, and comparing antiviral activity with cytotoxicity gives the selective index of a compound. They support antiviral drugs, antibodies and vaccine candidates at the preclinical stage.
